Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
Supreme Cannabis Company. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
Supreme Cannabis Company's
is considered below, and whether this is a fair price.
Price based on past earnings
Supreme Cannabis Company's earnings available for a low price, and how does
this compare to other companies in the same industry?
Supreme Cannabis Company's earnings are expected to grow significantly at over 20% yearly.
Supreme Cannabis Company's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
Supreme Cannabis Company's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
Supreme Cannabis Company
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
Supreme Cannabis Company's finances.
The net worth of a company is the difference between its assets and liabilities.
Supreme Cannabis Company is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Supreme Cannabis Company's cash and other short term assets cover its long term commitments.
This treemap shows a more detailed breakdown of
Supreme Cannabis Company's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
High level of physical assets or inventory.
Debt is covered by short term assets, assets are 1.3x debt.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Navdeep Dhaliwal, CA, is a Co-Owner of 2551448 Ontario Inc. Mr. Dhaliwal serves as Chief Executive Officer at Supreme Pharmaceuticals Inc. since September 24, 2018. Mr. Dhaliwal continues to focus on executing on Supreme Pharmaceuticals’ broader global growth strategy including M&A opportunities, strategic investments, and developing its international and medical businesses. He also continues to lead the Company’s investor and capital markets relations activities. Mr. Dhaliwal served as President of Supreme Pharmaceuticals Inc. since October 19, 2017 until September 24, 2018 and served as its Chief Financial Officer from April 25, 2016 to October 19, 2017. Mr. Dhaliwal serves as the Principal of NLX Capital Corp., a Toronto-based corporate development firm focused primarily on technology and renewable energy. He retained by a Toronto software company, where he successfully expanded its business into South East Asia, where he has extensive business experience. He has been involved in the Canadian medical marijuana space for two years prior to joining Supreme. He has been a Director of Supreme Pharmaceuticals Inc. since November 16, 2015. Mr. Dhaliwal served a Director of BlissCo Cannabis Corp. from February 22, 2018 to September 2018. He is a Chartered Accountant.
Navdeep's compensation has increased whilst company is loss making.
Navdeep's remuneration is higher than average for companies of similar size in Canada.
Management Team Tenure
Average tenure of the
Supreme Cannabis Company
management team in years:
The average tenure for the Supreme Cannabis Company management team is less than 2 years, this suggests a new team.
CEO & Director
Vice President of Corporate Development
General Manager of 7ACRES
Chief Financial Officer
Director of Operations
Chief Information Officer
VP of Stakeholder Relations & Corporate Secretary
Vice President of Marketing
Board of Directors Tenure
Average tenure and age of the
Supreme Cannabis Company
board of directors in years:
The tenure for the Supreme Cannabis Company board of directors is about average.
The Supreme Cannabis Company (TSE:FIRE) Share Price Is Up 508% And Shareholders Are Delighted
View our latest analysis for Supreme Cannabis Company Because Supreme Cannabis Company is loss-making, we think the market is probably more focussed on revenue and revenue growth, at least for now. … This free report showing analyst forecasts should help you form a view on Supreme Cannabis Company A Different Perspective While the broader market gained around 0.4% in the last year, Supreme Cannabis Company shareholders lost 7.9%. … Supreme Cannabis Company is not the only stock that insiders are buying.
The Supreme Cannabis Company, Inc. engages in the production of medical cannabis in Canada. The company was formerly known as Supreme Pharmaceuticals Inc. and changed its name to The Supreme Cannabis Company, Inc. in December 2017. The Supreme Cannabis Company, Inc. was incorporated in 1979 and is headquartered in Toronto, Canada.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.